Analysis of the results of the immunohistochemistry showed that the protein expression levels of AURKA, CAV1, and CDKN2A were all significantly different in HNSCC patients than in the normal group, which corroborated the results of the aforementioned RNA studies (Figure 9). Here, CDKN2A is linked to head and neck squamous cell carcinoma.